8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension

NCT00809926 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
451
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis